AVI BioPharma, Inc. (NASDAQ:AVII)
CAPS Rating:
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
Growing the love for investing
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This company recently changed it's management team and has made progress in obtaining govt. work. As with many companies, growing the federal allotment of funds provides stability & cashflow to accelerate growth. Look for federal funds to increase as well as new ventures.